Cyanocobalamin injections for patients without documented deficiency. Reasons for administration and patient responses to proposed discontinuation - PubMed (original) (raw)
. 1989 Apr 7;261(13):1920-3.
Affiliations
- PMID: 2926928
Cyanocobalamin injections for patients without documented deficiency. Reasons for administration and patient responses to proposed discontinuation
L Lawhorne et al. JAMA. 1989.
Abstract
We reviewed the records of 1222 patients who attended a newly acquired rural satellite clinic and found that 120 (10%) had been receiving regular cyanocobalamin injections, but that only 4 (3%) met accepted criteria for its administration. Open-ended interviews with 48 of these patients revealed that they had been receiving cyanocobalamin injections for a mean of 9.9 years for 3.3 symptoms each and with a mean effectiveness rating of 2.9 (scale, 0 to 4). After receiving education regarding the appropriate indications for cyanocobalamin injections, 25 (52%) of the patients were willing to stop receiving them at least temporarily. However, 18 patients (38%) who were younger and who reported greater symptom relief would actively seek a physician who would continue to administer cyanocobalamin. Our findings suggest that some patients who have been receiving cyanocobalamin injections but who do not have a documented deficiency will stop receiving the injections when presented with reasonable alternatives.
Comment in
- Dependence on cyanocobalamin injections.
[No authors listed] [No authors listed] JAMA. 1989 Sep 15;262(11):1468-9. JAMA. 1989. PMID: 2769891 No abstract available.
Similar articles
- Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: a dose-finding trial.
Eussen SJ, de Groot LC, Clarke R, Schneede J, Ueland PM, Hoefnagels WH, van Staveren WA. Eussen SJ, et al. Arch Intern Med. 2005 May 23;165(10):1167-72. doi: 10.1001/archinte.165.10.1167. Arch Intern Med. 2005. PMID: 15911731 Clinical Trial. - Anaphylactic reaction after intramuscular injection of cyanocobalamin (vitamin B12): a case report.
Bilwani F, Adil SN, Sheikh U, Humera A, Khurshid M. Bilwani F, et al. J Pak Med Assoc. 2005 May;55(5):217-9. J Pak Med Assoc. 2005. PMID: 15960291 - Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin.
Moloney FJ, Hughes R, O'Shea D, Kirby B. Moloney FJ, et al. Clin Exp Dermatol. 2008 Jul;33(4):412-4. doi: 10.1111/j.1365-2230.2007.02584.x. Epub 2008 May 21. Clin Exp Dermatol. 2008. PMID: 18498413 - Oral or intramuscular vitamin B12?
[No authors listed] [No authors listed] Drug Ther Bull. 2009 Feb;47(2):19-21. doi: 10.1136/dtb.2009.01.0002. Drug Ther Bull. 2009. PMID: 19193702 Review. - Is oral vitamin B12 as effective as intramuscular injection?
Kripke C. Kripke C. Am Fam Physician. 2006 Jan 1;73(1):65. Am Fam Physician. 2006. PMID: 16417065 Review. No abstract available.
Cited by
- A study of the prevalence of serum vitamin B12 and folic Acid deficiency in Western maharashtra.
Mahajan SK, Aundhakar SC. Mahajan SK, et al. J Family Med Prim Care. 2015 Jan-Mar;4(1):64-8. doi: 10.4103/2249-4863.152255. J Family Med Prim Care. 2015. PMID: 25810991 Free PMC article. - Indications for Vitamin B(12) Therapy: A retrospective study.
Delva MD, Anderson JE. Delva MD, et al. Can Fam Physician. 1992 Dec;38:2832-5. Can Fam Physician. 1992. PMID: 20469527 Free PMC article. - How I treat cobalamin (vitamin B12) deficiency.
Carmel R. Carmel R. Blood. 2008 Sep 15;112(6):2214-21. doi: 10.1182/blood-2008-03-040253. Epub 2008 Jul 7. Blood. 2008. PMID: 18606874 Free PMC article. - Oral vitamin B12 therapy in the primary care setting: a qualitative and quantitative study of patient perspectives.
Kwong JC, Carr D, Dhalla IA, Tom-Kun D, Upshur RE. Kwong JC, et al. BMC Fam Pract. 2005 Feb 21;6(1):8. doi: 10.1186/1471-2296-6-8. BMC Fam Pract. 2005. PMID: 15723708 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous